HARROW, INC. — Director's Dealing 2020

Jun 9, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HARROW HEALTH, INC. (HROW)
CIK: 0001360214
Period of Report: 2020-06-04

Reporting Person: BAUM MARK L (Director, Chief Executive Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-06-04	Employee Stock Option - Right to Buy	$7.87	D	600000	Disposed	2020-07-31	Common Stock (600000)	Direct
2020-06-04	Employee Stock Option - Right to Buy	$7.87	A	600000	Acquired	2025-07-31	Common Stock (600000)	Direct

Footnotes

F1: The two reported transactions involve an amendment of an outstanding option to extend the term of the option, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on July 31, 2015. The option provides for vesting in five installments based on the satisfaction of certain stock-price based performance targets during the term of such option.